5/10
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
There is one injury that can thwart both an all-star pitcher with the Chicago Cubs and a teen practicing to make the varsity team: a torn labrum.
Eighty-one students training in a diversity of health professions worked with regional and federal agencies to confront an imagined outbreak scenario centered around bubonic plague in Philadelphia.
A new study challenges common advice given to patients about whether topical creams increase radiation dose during cancer treatment.
A subset of T cells contributes to the inflammation and bone loss that characterizes periodontitis, a severe form of gum disease. According to new research by George Hajishengallis and scientists at the National Institutes of Health, drugs that specifically inhibit these cells may offer an effective therapy.
Gene therapies have had success in treating blindness but can’t save areas of the retina where cells have already died. In a new effort, School of Veterinary Medicine scientists John Wolfe and William Beltran will attempt to develop a stem-cell-based approach that restores vision.
Susan M. Domchek, Daniel E. Polsky, Marie Celeste Simon, and Rachel M. Werner are four of the 85 newly-elected members of the National Academy of Medicine.
The language people use in these social media posts can make these predictions as accurately as the tools clinicians use in medical settings to screen for the disease.
A new study shows patients with treatable mutations identified by liquid biopsies rather than tissue biopsies also largely respond to therapy.
New research led by Rumela Chakrabarti reveals how immune cells called myeloid-derived immunosuppressor cells contribute to the progression of triple-negative breast cancer, a particularly aggressive cancer. Pairing chemotherapy with a drug that blocks these cells may one day help stem its growth.
A Penn Medicine and CHOP team shows the first example of using base-editing tools to treat a disease in animal models in utero.
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →
Bruce Brod of the Perelman School of Medicine says that prolonged or overuse of topical steroids can cause rosacea, skin thinning, stretch marks, and an extreme and debilitating withdrawal.
FULL STORY →
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →